■ Announcement · August 1, 2026
Amgen Declares Q3 2026 Dividend of $2.52 per Share
Amgen's board declared a $2.52 per share dividend for Q3 2026, payable September 11 to shareholders of record August 21.
Dividend Declaration
Amgen (NASDAQ:AMGN) announced that its Board of Directors has declared a quarterly dividend of $2.52 per share for the third quarter of 2026. The dividend is scheduled to be paid on September 11, 2026, to stockholders of record as of the close of business on August 21, 2026.
About Amgen
Amgen is a biotechnology company focused on discovering, developing, manufacturing, and delivering innovative medicines to address serious illnesses. The company leverages biology and technology to serve millions of patients worldwide. Founded over 45 years ago in Thousand Oaks, California, Amgen helped establish the biotechnology industry and continues to advance a broad pipeline and portfolio targeting cancer, heart disease, inflammatory conditions, rare diseases, and obesity-related conditions.
Amgen is recognized for its innovation and workplace culture, with honors from Fast Company and Forbes. The company is a component of the Dow Jones Industrial Average and the Nasdaq-100 Index.
What it means for income investors
This dividend declaration continues Amgen's pattern of regular quarterly payments. The consistent payout provides a predictable income stream for shareholders, with the next payment scheduled for September 11, 2026.
Reporting based on: PR Newswire. Figures verified against market data where available.